Skip to main content
Clinical Trials/NCT00914264
NCT00914264
Completed
Not Applicable

The Continuous Positive Airway Pressure Effects on Chronic Obstructive Pulmonary Disease Patients With Obstructive Sleep Apnea

Chang Gung Memorial Hospital1 site in 1 country90 target enrollmentDecember 2008
ConditionsCOPD & OSA

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD & OSA
Sponsor
Chang Gung Memorial Hospital
Enrollment
90
Locations
1
Primary Endpoint
exercise performance
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

  1. The first objective of this study is to determine the differences between, while the airway obstruction severity is the same, and the acute continuous positive airway pressure (CPAP) effect on chronic obstructive pulmonary disease (COPD) patients with overlap syndrome compared with COPD patients without in terms of sleep quality, autonomic nerve activity, biologic markers of systemic inflammatory, and exercise performance.
  2. The second objective of this study is to evaluate the subacute (3 months treatment) CPAP effect on COPD patients with overlap syndrome in terms of pulmonary hemodynamic and right heart function, We will also determine the subacute effect of CPAP on sleep and life quality, autonomic nerve activity, biologic markers of systemic inflammatory, as well as exercise performance.
  3. The last objective of this study is to evaluate the long term (12 months treatment) CPAP effect on COPD patients with overlap syndrome. The un-scheduled clinic or emergency department visiting, hospitalization, or mortality will be recorded to see if there is significant treatment effect in terms of reducing morbidity and mortality. The long term CPAP effect on sleep and life quality, autonomic nerve activity, biologic markers of systemic inflammatory, exercise performance, as well as pulmonary hemodynamic and right heart function will be re-evaluation.

Detailed Description

COPD patients will be disturbed by season 12 months follow up is better than 18 months

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
December 2016
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chang Gung Memorial Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • chronic stable COPD
  • FEV1/FVC \< 70%
  • No response to beta-agonist
  • without acute exacerbation within2 months

Exclusion Criteria

  • Chronic respiratory failure (PaO2\<60 mmHg, PaCO2\>50 mmHg)
  • Clinical evidence of congestive heart failure
  • Facial defect and all the other condition that can't tolerate nasal mask
  • Malignancy

Outcomes

Primary Outcomes

exercise performance

Time Frame: 3 days, 3 & 12 months

the condition of COPD patient will be disturbed by season factor 12 months follow up will be better than 18 months

Secondary Outcomes

  • mortality and acute exacerbation(1, 5, 10 years)
  • autonomic nerve activity(3 days, 3 & 12 months)

Study Sites (1)

Loading locations...

Similar Trials